Background: Idiopathic juxtafoveolar telangiectasis (IJT) is a rare retinal vasculopathy of adulthood that may cause central loss of visual acuity. The purpose of this paper is to evaluate the type and distribution of fundus changes in patients with this disorder. Methods: Medical records of 19 patients with IJT using the Gass & Blodi classification were studied. Eight patients in group 1A (42%) and 11 in group 2A (58%) were analyzed. By projecting color photographs we divided the macula into four quadrants and studied the fundus changes in each one. Results: All patients in group 1A presented unilateral disease with easily seen telangiectasis, lipid deposits and cystic macular edema. The mean age of this group was 55.8 years. Five (63%) patients were male and 3 (37%) were female. All patients in group 2A, 2 males (18%) and 9 females (82%), had bilateral disease evidenced by fluorescein angiography. The mean age of this group was 54.5 years. Fundoscopic findings included: intraretinal pigment plaques, grayish coloring of the macular retina, superficial crystalline deposits, right-angle venules, subretinal and intraretinal neovascularization. Conclusions: All patients in this survey were adults. In group 1A, men were affected 2 times more often than women, and the main affected macular quadrant was the inferior temporal, followed by the inferior nasal. In group 2A, women were affected 4 times more often than men and all eyes had inferior and superior temporal macular quadrant involvement.

Keywords:
Idiopathic juxtafoveolar retinal telangiectasis, Macula
1.
Reese AB: Telangiectasia of the retina and Coats’ disease. Am J Ophthalmol 1956;42:1–8.
2.
Gass JDM, Oyakawa RT: Idiopathic juxtafoveal retinal telangiectasis. Arch Ophthalmol 1982;100: 769–780.
3.
Gass JDM, Blodi BA: Idiopathic juxtafoveal retinal telangiectasis: Update of classification and follow-up study. Ophthalmology 1993;100:1536–1546.
4.
Zografos L: Les télangiectasies idiopathiques juxta-fovéolaires, et la maladie de Leber-Coats. Opthalmologie 1987;2:175–185.
5.
Tripathy R, Ashton N: Electron microscopical study of Coats’disease. Br J Ophthalmol 1971;55:289–301.
6.
Casswell AG, Chaine G, Rush P, Bird AC: Paramacular telangiectasis. Trans Ophthalmol Soc UK 1986;105:683–692.
7.
Green WR, Quigley HA, De la Cruz Z, Cohen B: Parafoveal retinal telangiectasis: Light and electron microscopy studies. Trans Ophthalmol Soc UK 1980;100:162–170.
8.
Park D, Schatz H, McDonald HR, Johnson RN: Fibrovascular tissue in bilateral juxtafoveal telangiectasis. Arch Ophthalmol 1996;114:1092–1096.
9.
Moisseiev J, Lewis H, Bartov E, Fine SL, Murphy RP: Superficial retinal refractile deposits in juxtafoveal telangiectasis. Am J Ophthalmol 1990;109:604–605.
10.
Millary RH, Klein ML, Hadelmsn IL, Watzke RC: Abnormal glucose metabolism and parafoveal telangiectasis. Am J Ophthalmol 1986;102:363–370.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.